RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES
Autor: | A. Koumarianou, Argyris Symeonidis, Leylagül Kaynar, Saime Paydas, Nikolaos Kanellias, Chezi Ganzel, G. Isenberg, Themistoklis Karmiris, Olga Meltem Akay, E. Megalakaki, M. Ozgur, George Karianakis, Eleftheria Hatzimichael, Miri Zektser, M. Palassopoulou, Eirini Katodritou, O. Gutwein, Chrysovalantou Chatzidimitriou, Stamatios Karakatsanis, Maria Tsirogianni, Tulin Firatli Tuglular, Maria K. Angelopoulou, Z. Mellios, Anat Gafter-Gvili, Effimia Vrakidou, T.P. Vassilakopoulos, Gabriella Gainaru, Christina Kalpadakis, A. C. Atalar, Ronit Gurion, Marina P. Siakantaris, Panayiotis Tsirigotis, Panagiotis Zikos, Sotirios G. Papageorgiou, Burhan Ferhanoglu, Theoni Leonidopoulou, Tamar Tadmor, Netanel A. Horowitz, A. Piperidou |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Hematological Oncology. 39 |
ISSN: | 1099-1069 0278-0232 |
Databáze: | OpenAIRE |
Externí odkaz: |